Xenon Pharmaceuticals (XENE) Preferred Shares (2013 - 2021)

Xenon Pharmaceuticals (XENE) has 6 years of Preferred Shares data on file, last reported at $7.7 million in Q4 2021.

• On a quarterly basis, Preferred Shares changed 0.0% year-over-year to $7.7 million in Q4 2021; TTM through Dec 2021 was $7.7 million, a 0.0% change from a year earlier, with the FY2021 full-year figure at $7.7 million, changed 0.0% from the prior year.
• Preferred Shares for Q4 2021 stood at $7.7 million, roughly flat from $7.7 million in the prior quarter.
• Over the last five years, Preferred Shares for XENE reached as high as $21.8 million in Q1 2018 and fell as low as $7.7 million in Q4 2018.
• Historically, Preferred Shares has averaged $9.8 million across 4 years, with a median of $7.7 million in 2018.
• On a YoY basis, Preferred Shares climbed as much as 0.0% in 2019 and fell as far as 64.57% in 2019.
• Year by year, Preferred Shares stood at $7.7 million in 2018, then changed by 0.0% to $7.7 million in 2019, then changed by 0.0% to $7.7 million in 2020, then changed by 0.0% to $7.7 million in 2021.
• Per Business Quant data, the three most recent Preferred Shares figures were $7.7 million in Q4 2021, $7.7 million in Q3 2021, and $7.7 million in Q2 2021.